L ymphedema (LE) is the accumulation of interstitial fluid as a result of dysfunction within the lymphatic system (Ridner, 2013) . Recent evidence suggests that one in five women will develop upper extremity LE as a result of their breast cancer treatment (DiSipio, Rye, Newman, & Hayes, 2013) , which means that over 600,000 women have or will develop this chronic and potentially disabling condition. On average, LE occurs within 14 months after breast cancer surgery. However, some cases are reported 20 years after surgery. Untreated, LE worsens and leads to significant disability and reduced quality of life (Kwan et al., 2002) . Identification of risk factors for and mechanisms that contribute to the development and progression of LE will facilitate earlier treatment and, in turn, reduce the significant negative sequelae associated with this condition.
Findings on the specific risk factors for the development of LE are highly variable. Axillary lymph node dissection (ALND), higher body mass index (BMI), more lymph nodes removed, field of radiation, postoperative seroma, infection, early edema, and surgery plus radiation are linked to the development of LE (Bevilacqua et al., 2012; Dominick, Madlensky, Natarajan, & Pierce, 2013; Paskett, Dean, Oliveri, & Harrop, 2012) . However, it is unclear why-in the presence of similar phenotypic risk factors-some women develop LE and others do not.
In our previous studies (Leung et al., 2014; Miaskowski et al., 2013) , increased BMI, increased number of lymph nodes removed, higher stage of disease at diagnosis, and having had an ALND were associated with an increased risk for LE. Preliminary findings from our research group (Leung et al., 2014; Miaskowski et al., 2013) and others (Finegold et al., 2008 (Finegold et al., , 2012 Newman et al., 2012) suggest that variations in lymphatic, angiogenic, and proinflammatory cytokine genes are associated with increased risk for the development of LE after breast cancer treatment. However, these associations did not explain all of the variability in the occurrence of LE. Therefore, additional research is needed to identify other biological pathways that contribute to the development and progression of secondary LE. Because the etiology of LE is multifactorial, information on genetic variations in other biological pathways involved in the lymphatic system that are associated with LE can lead to the identification of high-risk patients.
Intrinsic lymphatic pump mechanisms facilitate the transport of lymph (Stanton, Modi, Mellor, Levick, & Mortimer, 2009 ) and play a key role in the function of the lymphatic system. Lymph flow is facilitated by phasic contractions that occur in collecting lymphatic vessels. These contractions, and resultant pumping action, are an intrinsic property of lymphatic smooth muscles and are a result of action potentials in the smooth muscle cells in the vessel walls. Potassium (K + ) channels, the most widely distributed types of ion channels, span cell membranes of vascular smooth muscle cells in the microcirculation, and are selective for K + ions. K + channels participate in the sodium-K + pump that generates an electrochemical gradient across cell membranes. Movement of K + across these membranes sets or resets the resting membrane potential and helps shape the action potential. Ion movement and cell excitability are essential components of the intrinsic pump mechanism, which facilitates lymph transport. Deficits in this pumping mechanism may compromise lymph flow (Telinius et al., 2014; von der Weid et al., 2012) . Preclinical models suggest that ATP-activated K + channels in lymphatic smooth muscle and endothelium mediate lymphatic pump activity (Kousai, Mizuno, Ikomi, & Ohhashi, 2004) . Telinius et al. (2014) found that the major classes of K + channels have a role in the regulation of spontaneous contractions in the thoracic duct in humans. Because of their role in establishing and reestablishing normal voltage differentials across the cell membrane, K + channels play an important role in lymph pump activity and lymph transport. Yet, no studies were identified that evaluated for associations between polymorphisms in K + channel genes and the development of LE following breast cancer surgery. Therefore, the purpose of this study was to determine if variations in K + channel genes were associated with the development of LE following breast cancer treatment. Leung et al. (2014) and Miaskowski et al. (2013) .
METHODS

Study Samples and Procedures
LE Study
The LE study used a cross-sectional design to evaluate for differences in phenotypic and genotypic characteristics in women with (n = 70) and without a diagnosis of LE (n = 71 After obtaining informed consent, the patient completed the enrollment questionnaires, prior to surgery. Following the completion of the questionnaires, the research nurse performed the objective measurements: height, weight, and BIS. A blood sample was drawn for genomic analyses. Patients were contacted 2 weeks after surgery to schedule the first postsurgical appointment. The research nurse met with the patients either in their home or in the Clinical Research Center at 1, 2, 3, 4, 5, 6, 8, 10 , and 12 months after surgery. In the second through fifth years of the study, patients were seen every 4 months. During each of the study visits, the women completed the study questionnaires and had the objective measures done by the research nurse.
Self-Report Measures
A demographic questionnaire was used to obtain information on age, marital status, education, ethnicity, employment status, living situation, and financial status. Functional status was evaluated using the Karnofsky Performance Status (KPS) Scale; KPS scores have well-established validity and reliability (Karnofsky, 1977) . The KPS Scale ranged from 30 (I feel severely disabled and need to be hospitalized) to 100 (I feel normal; I have no complaints or symptoms). Patients were asked to indicate if they exercised on a regular basis (yes/no). Clinical information was obtained from patient interviews and medical record reviews.
The Self-Administered Comorbidity Questionnaire (SCQ) is a short and easily understood instrument that was developed to measure comorbidity in clinical and health service research settings (Sangha, Stucki, Liang, Fossel, & Katz, 2003) . The questionnaire consists of 13 common medical conditions that were simplified into language that could be understood without any prior medical knowledge. Patients were asked to indicate if they had the condition using a yes/no format. If they indicated that they had a condition, they were asked if they received treatment for it and whether it limited their activities. For each condition, a patient can receive a maximum of 3 points. Total SCQ scores can range from 0 to 39. SCQ scores have wellestablished validity and reliability and has been used in studies of patients with a variety of chronic conditions (MacLean, Littenberg, & Kennedy, 2006; Sangha et al., 2003; Smith, Zimmerman, Williams, & Zebrack, 2009 ).
Objective Measures
For both studies, BIS measurements of the affected and unaffected arm were done using the procedures described by Cornish et al. (2000) and Hayes, Cornish, and Newman (2005) . Patients were instructed not to exercise or take a sauna within 8 hours of the assessment. In addition, they were asked to refrain from drinking alcohol for 12 hours prior to the assessment. In the LE study, the LE diagnosis was known based on a previous diagnosis by the patient's healthcare provider. In the LE study, BIS measurements were taken using the SFB7 device (ImpediMed, San Diego, CA). The Quantum X Bioelectrical Impedance Device (RJL Systems, Clinton Township, MI) was used in the Breast Symptoms Study. Women removed all jewelry, and their skin was prepped with an alcohol wipe prior to surface electrode placement. Patients laid supine on a massage table with their arms 30°from the body and legs not touching for at least 10 minutes prior to the BIS measurements.
Electrodes were placed on the dorsum of the wrists adjacent to the ulnar styloid process, the dorsum of the hands just proximal to the third metacarpophalangeal joint, anterior to the ankle joints between the malleoli, and over the dorsum of the feet over the third metatarsal bone just proximal to the third metatarsophalangeal joint. Two "measurement" electrodes were placed at either end of the 40-cm length over which the circumference measurements were made and the "drive" electrodes were placed 8-10 cm distal to these measurement electrodes. Two readings of resistance were obtained from the affected and unaffected arms, and each arm averaged for subsequent analyses.
Although cases and noncases of LE were known in the LE study, for the Breast Symptoms Study, LE cases were determined based on the procedures of Cornish et al. (2000) and Hayes et al. (2005) using all of the data obtained from each woman during her participation in the study. A woman was defined as an LE case if the ratio of the resistance in the untreated arm to the resistance in the treated arm was >1.139 for those women who had surgery on the dominant side or >1.066 for those women who had surgery on the nondominant side, at any of the BIS assessments.
Analysis of Phenotypic Data
Descriptive statistics and frequency distributions were generated on the sample characteristics. Independent sample t-tests, χ 2 tests for independence, and Mann-Whitney U tests were done to evaluate for differences in demographic and clinical characteristics between patients with and without LE. Data were analyzed using SPSS 6 SNPs and 5 haplotypes; KCNK9: 17 SNPs and 10 haplotypes) passed all quality control filters and were included in the genetic association analyses. Regional annotations were identified using the University of California Santa Cruz Human Genome Browser GRCh37/hg19 (http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19). Potential regulatory involvement of SNPs was investigated using the ENCODE data tracks for Transcription Factor ChIP-seq (i.e., wgEncodeAwgTfbsUniform, wgEncodeRegTfbsClusteredV30), H3K27Ac Mark (wgEncodeRegMarkH3k27ac), H3K4Me1 Mark (wgEncodeRegMarkH3k4me1), DNaseI Hypersensitivity Clusters (i.e., wgEncodeRegDnaseClustered), and the TargetScan miRNA Regulatory Sites (i.e., targetScanS) tracks (Karolchik et al., 2014 (Gabriel et al., 2002) . For SNPs that were members of the same haploblock, haplotype analyses were conducted in order to localize the association signal within each gene and to determine if haplotypes improved the strength of the association with the phenotype. Haplotypes were constructed using the program PHASE version 2.1 (Stephens, Smith, & Donnelly, 2001) . In order to improve the stability of haplotype inference, the haplotype construction procedure was repeated five times using different seed numbers with each cycle. Only haplotypes that were inferred with probability estimates of ≥.85, across the five iterations, were retained for downstream analyses. Haplotypes were evaluated assuming a dosage model (i.e., analogous to the additive model).
Ancestry informative markers were used to minimize confounding due to population stratification (Hoggart et al., 2003; Tian, Gregersen, & Seldin, 2008) . Homogeneity in ancestry among patients was verified by principal component analysis (Price et al., 2006) , using Helix Tree (Golden Helix, Bozeman, MT). Briefly, the number of principal components (PCs) that distinguished the major racial/ethnic groups in the sample by visual inspection of scatter plots of orthogonal PCs (i.e., PC1 vs. PC2, PC2 vs. PC3) were sought. This procedure was repeated until no discernible clustering of patients by their self-reported race/ethnicity was possible (data available on request). One hundred six ancestry informative markers were included in the analysis. The first three PCs were selected to adjust for potential confounding due to racial/ethnic population substructure by including the three PCs as covariates in all regression models.
For association tests, three genetic models were assessed for each SNP: additive, dominant, and recessive. Barring trivial improvements (i.e., delta <10%), the genetic model that best fits the data (i.e., the model with the smallest p value) was selected for each SNP. A logistic regression analysis that controlled for significant covariates, as well as genomic (i.e., three PCs) and self-reported race/ethnicity, was used to evaluate the relationship between genotype and LE group membership. A backwards stepwise approach was used to create the most parsimonious model. Genetic model fit and both unadjusted and covariate-adjusted odds ratios were estimated using STATA version 14.
As was done in our previous studies (Illi et al., 2012; McCann et al., 2012) , based on recommendations in the literature (Hattersley & McCarthy, 2005; Rothman, 1990) , the implementation of rigorous quality controls for genomic data, the nonindependence of SNPs/haplotypes in LD, and the exploratory nature of the analyses, adjustments were not made for multiple testing. In addition, significant SNPs identified in the bivariate analyses were evaluated further using regression analyses that controlled for differences in phenotypic characteristics, potential confounding due to population stratification, and variation in other SNPs/haplotypes within the same gene. Only those SNPs that remained significant were included in the final presentation of the results. Therefore, the significant independent associations reported are unlikely to be due solely to chance. Unadjusted (bivariate) associations are reported for all SNPs, and haplotypes passing quality control criteria are shown (see Table, Supplementary Digital Content 1, http:// links.lww.com/NRES/A213) to allow for subsequent comparisons and meta-analyses.
RESULTS
Demographic and Clinical Characteristics
Demographic and clinical characteristics that differed between groups are presented in Table 1 . Women with LE had a higher BMI, had a lower KPS score, were more likely to have lung disease, and had more advanced disease. They were less likely to have had a sentinel lymph node biopsy and more likely to have had ALND. Women with LE had a higher number of lymph nodes removed and had more positive nodes. They were more likely to have received adjuvant chemotherapy, radiation therapy, and/or a combination of therapies. 
Candidate Gene Analyses for the Development of LE
Regression Analyses of KCNA1, KCNJ3, KCNJ6, and KCNK3 Genotypes and the Development of LE
Multivariate logistic regression models were fit to better estimate the magnitude of the association between genotype and the development of LE. As shown in Table 2 , in addition to genotype, the phenotypic characteristics included in the regression models were ethnicity, BMI, stage of disease, having a sentinel lymph node biopsy, and number of lymph nodes removed. Receipt of adjuvant chemotherapy and radiation therapy, although not significant after the inclusion of genomic and self-reported race/ethnicity, was retained in all of the regression models for face validity.
As shown in Figure 1A -F, the only genetic associations that remained significant in the multivariate logistic regression analyses were for KNCA1 rs4766311, KCNJ3 rs1037091, KCNJ6 rs2211845, KCNJ6 rs991985, KCNJ6 rs2836019, and KCNK3 rs1662988.
In the regression analysis for KNCA1 rs4766311, carrying two doses of the rare T allele (i.e., CC+CT vs. TT) was associated with 59% lower odds of being in the LE group. In the Note. Additional information about demographic and clinical characteristics is available in Leung et al. (2014) and Miaskowksi et al. (2013) . SCQ = Self-Administered Comorbidity Questionnaire, SD = standard deviation.
a Stage of disease was classified using American Joint Committee on Cancer staging system. regression analysis for KCNJ3 rs1037091, having one or two doses of the rare A allele (i.e., GG vs. GA+AA) was associated with 48% lower odds of being in the LE group. For the three KCNJ6 SNPs, each was included individually in its own regression and then together in a single regression. For KCNJ6 rs2211845, having one or two doses of the rare C allele (i.e., Note. In each model, the first three principal components identified from the analysis of ancestry informative markers as well as self-report of race/ethnicity (i.e., White, Black, Asian/Pacific Islander, Hispanic/Mixed ethnic background/Other) were retained to adjust for potential confounding due to race/ethnicity (data not shown TT vs. TC+CC) was associated with a 1.9-fold greater odds of being in the LE group. For KCNJ6 rs991985, having two doses of the rare A allele (i.e., CC+CT vs. AA) was associated with almost a 2.2-fold higher odds of being in the LE group. For KCNJ6 rs2836019, having one or two doses of the rare T allele (i.e., CC vs. CT+TT) was associated with 46% lower odds of being in the LE group. In the regression analysis for KCNK3 rs1662988, having one or two doses of the rare T allele (i.e., CC vs. CT+TT) was associated with 46% lower odds of being in the LE group.
DISCUSSION
This study is the first to evaluate for associations between polymorphisms in K + channel genes and the development of LE following breast cancer surgery. Details on phenotypic differences in this sample were reported previously (Leung et al., 2014; Miaskowski et al., 2013) . Therefore, this discussion will focus on the K + channel genes found to have a significant association with LE. After controlling for significant phenotypic characteristics, as well as self-reported and genomic estimates of race/ethnicity, six SNPs across four K + channel genes were found to be associated with the occurrence of LE. Interestingly, SNPs were identified in genes for each of three families of K + channels that were evaluated: voltage-gated, inwardrectifying, and two-pore K + channel genes.
Voltage-Gated K + Genes
Although genes for three types of voltage-gated K + channels were evaluated in this study, only KCNA1 was associated with LE classification. Specifically, for the SNP rs4766311, carrying two doses of the rare T allele was associated with lower odds of being in the LE group. In humans, KCNA1 encodes for the K + voltage-gated channel subfamily A, member 1 (Kv1.1). A variety of voltage-gated K + channels are expressed across the cell membranes of smooth muscles cells in the microcirculation. During the action potential, voltage-gated K + channels are essential in shaping the action potential or returning the depolarized membrane to its resting state (Jackson, 2005; Miller, 2000) . These functions act to regulate the excitability of smooth muscle cells. Voltage-gated K + channels may regulate the frequency and the amplitude of the spontaneous smooth muscle contractions in lymphatic collectors and ducts FIGURE 1. Differences between the lymphedema and no lymphedema groups. Panel A shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous or heterozygous for the common allele (CC+CT) or homozygous for the rare allele (TT) for rs4766311 in KCNA1. Panel B shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous for the common allele (GG) or heterozygous or homozygous for the rare allele (GA+AA) for rs1037091 in KCNJ3. Panel C shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous for the common allele (TT) or heterozygous or homozygous for the rare allele (TC+CC) for rs2211845 in KCNJ6. Panel D shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous or heterozygous for the common allele (CC+CA) or homozygous for the rare allele (AA) for rs991985 in KCNJ6. Panel E shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous for the common allele (CC) or heterozygous or homozygous for the rare allele (CT+TT) for rs2836019 in KCNJ6. Panel F shows differences between the lymphedema and no lymphedema groups in the percentages of patients who were homozygous for the common allele (CC) or heterozygous or homozygous for the rare allele (CT+TT) for rs1662988 in KCNJ3. (Telinius et al., 2014) . Polymorphisms in KCNA1 have been linked to episodic ataxia and myokymia (D'Adamo et al., 2015) . KCNA1 rs4766311, located in the 3′ untranslated region of the gene, has no known function.
Inward-Rectifying K + Genes
Of the four inward-rectifying genes evaluated, KCNJ3 and KCNJ6 were found to be associated with LE. For KCNJ3 rs1037091, having one or two doses of the rare allele A was associated with a lowered odds of being in the LE group. KCNJ3 encodes for the G-protein inward-rectifying potassium channel, subfamily J, member 3p (Kir3.1 or GIRK1). For KCNJ6 rs2211845, having one or two doses of the rare C allele was associated with an increased odds of being in the LE group. For KCNJ6 rs991985, having two doses of the rare A allele was associated with an increased odds of being in the LE group. For KCNJ6 rs2836019, having one or two doses of the rare T allele was associated with a lower odds of being in the LE group. KCNJ6 encodes for the G-protein inwardrectifying potassium channel, subfamily J, member 6p (Kir3.2 or GIRK2).
In contrast to voltage-gated K + channels, which are outward rectifying, the inward-rectifying channels conduct more K + current into the cell than outward. These channels function to stabilize the cell's resting membrane potential near the K + equilibrium potential until the threshold potential is reached. Alterations in GIRK1 channels have been associated with epilepsy (Chioza et al., 2002) and atrial fibrillation (Brundel et al., 2001) . In this same sample, different polymorphisms in both the GIRK1 and GIRK2 genes were associated with the occurrence of breast pain (Langford et al., 2014 (Langford et al., , 2015 . Polymorphisms in the GIRK2 gene have been associated with postoperative pain, pain sensitivity, and addiction (Nishizawa et al., 2014) . The significant SNPs in KCNJ3 and KCNJ6 identified in this study are located in the intronic region of the genes and have no known function.
Two-Pore K + Channel Gene
Of the three two-pore K + channel genes evaluated, only KCNK3 was associated with LE. For KCNK3 rs1662988, having one or two doses of the rare T allele was associated with a lower odds of being in the LE group. KCNK3 encodes for the two-pore potassium channel, domain subfamily K, member 3 (TASK-1). Two-pore K + channels give rise to background, or leak, K + currents, which play a role in the maintenance of the resting membrane potential. TASK-1 channels are sensitive to changes in extracellular pH and are inhibited by increased extracellular acidity (Lesage & Lazdunski, 2000) . KCNK3 rs1662988 is located in the intronic region of the gene, with no known function.
Limitations
Study limitations warrant consideration. Our sample size precluded analysis of interaction effects and genome-wide association studies. Larger sample sizes may reveal additional associations between polymorphisms in K + channel genes and LE. In addition, we did not evaluate every type of potassium channel gene. Future studies are needed to confirm these preliminary findings and to evaluate the functional effects of these polymorphisms.
Conclusions
Despite these limitations, the preliminary findings from this study suggest that polymorphisms in K + channel genes are associated with the occurrence of LE following breast cancer surgery. Phasic contractions of the smooth muscles in lymphatic vessels contribute to the intrinsic lymph pump mechanism, which facilitates lymph transport. These contractions depend in part on K + channel regulation of the smooth muscle cell resting membrane potential and the shaping of the action potential. Alterations in K + channels may affect the excitability of the smooth muscle cell membrane and modify lymph pump activity. This study identified six polymorphisms across four K + channel genes (i.e., KCNA1, KCNJ3, KCNJ6, KCNK3) that were significantly associated with the occurrence of LE after breast cancer surgery. At this time, these polymorphisms do not have known functional consequences. However, they may be in LD with functional polymorphisms. Given that associations were found between the occurrence of LE and polymorphisms in K + channel genes, cytokine genes, and genes involved in lymphangiogenesis and angiogenesis, the mechanisms that underlie the development of LE are likely to be multifactorial. Therefore, additional research with larger samples is needed to evaluate the relative contribution of these different pathways in the development of LE. However, the identification of genetic risk factors for secondary LE may allow for the early detection and implementation of risk reduction strategies for those women at higher risk for this chronic and potentially disabling condition.
